Illumina To Sell Grail After U.S. Antitrust Ruling
Investor's Business DailyIllumina said Sunday it will the sell cancer detection startup after a U.S. appeals court said the $7.1 billion deal violated antitrust laws,
The post Illumina To Sell Grail After U.S. Antitrust Ruling appeared first on Investor's Business Daily.